Arthritis, Rheumatoid: all 2,962 studies

Page 8 of 30. Open to participants first (396), then studies with results posted, then the rest; newest registration first within each.

• Arcos Revision Stem: Evaluation of Clinical PerformanceCompletedNCT01820611Results posted
• ARMONIA: An Observational Study of Biologic Drugs in Monotherapy or Combination With DMARDs in Italian Clinical Practice and the Efficacy and Safety of RoActemra/Actemra (Tocilizumab) Monotherapy in Patients With Rheumatoid ArthritisCompletedNCT01791205Results posted
• Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological AgentsCompletedNCT01783730Results posted
• Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus MethotrexateTerminatedNCT01783015Phase 4Results posted
• Rheumatoid Arthritis Patients on Adalimumab to Evaluate Its Effect on Synovitis Using Ultrasonography in an Egyptian PopulationTerminatedNCT01782469Results posted
• A Long-Term Extension Study of WA22763 and NA25220 of Subcutaneous RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT01772316Phase 3Results posted
• Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents.TerminatedNCT01770379Phase 3Results posted
• Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical PracticeCompletedNCT01768858Results posted
• To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)CompletedNCT01768572Phase 3Results posted
• An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus MethotrexateTerminatedNCT01764997Phase 3Results posted
• Physical Activity in Patients With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical PracticeCompletedNCT01756235Results posted
• Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With AdalimumabCompletedNCT01752855Phase 2Results posted
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate TherapyCompletedNCT01751776Phase 1Results posted
• This Study is Randomised, Single Oral Dose Bioequivalence Study of Meloxicam GSK 15 MG Tablets.CompletedNCT01750931Not applicableResults posted
• Co-Administration Of Methotrexate And CP-690,550CompletedNCT01745055Phase 1Results posted
• An Observational Study of Tocilizumab (Actemra) in Participants With Moderate to Severe Rheumatoid ArthritisCompletedNCT01741688Results posted
• Exposure Study Comparing 3 Routes of Methotrexate (MTX) AdministrationCompletedNCT01737944Phase 1/2Results posted
• Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical PracticeCompletedNCT01736189Results posted
• A Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA).CompletedNCT01734993Phase 3Results posted
• "Learning About Biologics"-Rheumatoid ArthritisCompletedNCT01721200Not applicableResults posted
• A Study in Moderate to Severe Rheumatoid Arthritis ParticipantsCompletedNCT01721057Phase 3Results posted
• A Moderate to Severe Rheumatoid Arthritis StudyCompletedNCT01721044Phase 3Results posted
• Musculoskeletal Ultrasound in Predicting Early Dose Titration With TocilizumabCompletedNCT01717859Phase 4Results posted
• A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid ArthritisCompletedNCT01715896Phase 2Results posted
• A Long-term Safety Extension Study of Tocilizumab in Brazilian Participants With Rheumatoid Arthritis (RA) Who Completed the Studies ML21530 and MA21488CompletedNCT01715831Phase 4Results posted
• A Long Term Safety Study of Mavrilimumab in Adult Subjects With Rheumatoid ArthritisTerminatedNCT01712399Phase 2Results posted
• A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and SafetyCompletedNCT01712178Phase 2Results posted
• A Study in Participants With Moderate to Severe Rheumatoid ArthritisCompletedNCT01711359Phase 3Results posted
• A Study in Moderate to Severe Rheumatoid ArthritisCompletedNCT01710358Phase 3Results posted
• To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)CompletedNCT01709578Phase 3Results posted
• A Study of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid ArthritisCompletedNCT01706926Phase 2Results posted
• A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in MonotherapyCompletedNCT01705730Results posted
• Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking AgentsTerminatedNCT01691014Results posted
• A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or SulfasalazineCompletedNCT01689532Phase 3Results posted
• Observational Study of Tocilizumab in Participants With Rheumatoid Arthritis in AustraliaCompletedNCT01683604Results posted
• Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid ArthritisTerminatedNCT01682512Phase 3Results posted
• Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)TerminatedNCT01676701Phase 3Results posted
• A Non-Interventional Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT01672970Results posted
• A Non-Interventional Study Evaluating Rheumatoid Arthritis Participants Treated With Tocilizumab (RoActemra/Actemra)CompletedNCT01671059Results posted
• A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT01670045Results posted
• An Observational Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid ArthritisCompletedNCT01669902Results posted
• A Long Term Extension Study of WA19926 (NCT01007435) of Tocilizumab (RoActemra/Actemra) in Participants With Early, Moderate to Severe Rheumatoid Arthritis (RA)CompletedNCT01668966Phase 3Results posted
• A Long-Term Extension Study to WA19926 (NCT01007435) of Tocilizumab in Participants With Early, Moderate to Severe Rheumatoid ArthritisTerminatedNCT01665430Phase 3Results posted
• An Extension Study of WA19926 of the Long-Term Safety of Tocilizumab (RoActemra/Actemra) in Patients With Early Moderate to Severe Rheumatoid ArthritisCompletedNCT01664598Phase 3Results posted
• An Observational Study in Clinical Practice Management of Patients With Biological Drugs in MonotherapyCompletedNCT01664117Results posted
• A Study to Evaluate Tocilizumab Treatment in a Real-Life SettingCompletedNCT01664104Results posted
• A Non-Interventional Study in Patients With Moderate to Severe Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)CompletedNCT01663506Results posted
• A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Severe Rheumatoid Arthritis (RA)CompletedNCT01662063Phase 3Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate DosageTerminatedNCT01661140Phase 4Results posted
• A Long-Term Extension Study of WA19926 on the Safety of Tocilizumab (RoActemra/Actemra) in Participants With Early Moderate to Severe Rheumatoid ArthritisCompletedNCT01655381Phase 3Results posted
• A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety, Tolerability, and Efficacy of MK-8457 in Participants With Rheumatoid Arthritis (MK-8457-010)TerminatedNCT01651936Phase 2Results posted
• A Long-Term Safety Extension Study of WA19926 in Participants With Rheumatoid ArthritisCompletedNCT01649804Phase 3Results posted
• Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics RegistryCompletedNCT01646385Results posted
• A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate TherapyCompletedNCT01645280Phase 2Results posted
• Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04)CompletedNCT01643928Not applicableResults posted
• An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) AgentCompletedNCT01641952Results posted
• A Retrospective Chart Review on the Use of Biologics in Monotherapy for the Treatment of Patients With Rheumatoid ArthritisCompletedNCT01640548Results posted
• A Long Term Study to Assess the Safety of Fostamatinib in Patients in Asia With Rheumatoid ArthritisTerminatedNCT01640054Phase 2Results posted
• A Study to Continue ASP015K Treatment to Rheumatoid Arthritis Patients Who Completed Phase IIb Study or Phase III Study of ASP015KCompletedNCT01638013Phase 3Results posted
• Prospective Evaluation of the Radiographic Efficacy of EnbrelCompletedNCT01623752Results posted
• Acupuncture Study on Rheumatoid Arthritis, Monitoring Microbiome and BloodCompletedNCT01619176Not applicableResults posted
• Comparison of Methotrexate (MTX) and the VIBEX™ MTX DeviceCompletedNCT01618968Phase 2Results posted
• Actual Human Use of Methotrexate (MTX) Subcutaneously Administered Via the VIBEX™ MTX Auto-Injector DeviceCompletedNCT01618955Phase 2Results posted
• N-3 PUFA and Rheumatoid Arthritis in KoreaCompletedNCT01618019Not applicableResults posted
• A Study of Tocilizumab in Participants With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Non-Biological Disease-modifying Anti-rheumatic Drugs (DMARDs)CompletedNCT01617005Results posted
• A Non-Interventional Study in Rheumatoid Arthritis Patients Treated With Tocilizumab (RoActemra/Actemra)CompletedNCT01613378Results posted
• An Observational Study of MabThera in Participants With Severe Active Rheumatoid ArthritisCompletedNCT01613027Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs (REMISSION)CompletedNCT01610791Phase 3Results posted
• A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T)CompletedNCT01606761Phase 3Results posted
• A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D)CompletedNCT01604343Phase 3Results posted
• An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha TherapyCompletedNCT01592292Results posted
• Inflammation and the HeartCompletedNCT01589770Not applicableResults posted
• A Study of RoActemra/Actemra (Tocilizumab) With or Without Methotrexate in Patients With Mild to Moderate Rheumatoid Arthritis With an Inadequate Response to MethotrexateCompletedNCT01587989Phase 3Results posted
• Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid ArthritisCompletedNCT01579006Results posted
• Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to ScreeningCompletedNCT01578850Phase 4Results posted
• A Study of LY2127399 in Rheumatoid ArthritisTerminatedNCT01576549Phase 2Results posted
• Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008)TerminatedNCT01569152Phase 2Results posted
• Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid ArthritisTerminatedNCT01569074Phase 2Results posted
• Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid ArthritisCompletedNCT01563978Phase 2Results posted
• A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid ArthritisCompletedNCT01562327Results posted
• Crossover Study of Safety and Tolerability of Two Formulations of Adalimumab.CompletedNCT01561313Phase 2Results posted
• Good EULAR Response In Patients With Early Rheumatoid ArthritisCompletedNCT01558089Results posted
• An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-InhibitorCompletedNCT01557348Results posted
• Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)CompletedNCT01557322Results posted
• RHYTHM (Formerly Escape II Myocardium)CompletedNCT01548768Phase 4Results posted
• An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid ArthritisCompletedNCT01543503Results posted
• The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid ArthritisTerminatedNCT01533714Phase 2Results posted
• A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)CompletedNCT01526057Phase 2Results posted
• A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid ArthritisCompletedNCT01521923Phase 3Results posted
• Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α TherapyCompletedNCT01521884Results posted
• A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid ArthritisCompletedNCT01519791Phase 3Results posted
• A Crossover Study of the Safety and Tolerability of Two Formulations of AdalimumabCompletedNCT01502423Phase 2Results posted
• Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to MethotrexateCompletedNCT01500278Phase 4Results posted
• A Study To Evaluate The Effect Of CP-690,550 On Measures Of Kidney Function In Patients With Active Rheumatoid ArthritisCompletedNCT01484561Phase 1Results posted
• An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical PracticeCompletedNCT01474291Results posted
• Oral Baricitinib (LY3009104)Treatment in Japanese Participants With Active Rheumatoid Arthritis on Background Methotrexate TherapyCompletedNCT01469013Phase 2Results posted
• A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) TreatmentCompletedNCT01468077Phase 2Results posted
• A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid ArthritisCompletedNCT01462162Results posted
• Efficacy Confirmation Study of CDP870 in Early Rheumatoid ArthritisCompletedNCT01451203Phase 3Results posted
• Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid ArthritisCompletedNCT01443364Phase 4Results posted

← Arthritis, Rheumatoid overview